https://www.taxtmi.com/news?id=2427 The statement identifies non tariff barriers to pharmaceutical trade arising from the Therapeutic Goods Administration approval process, which lacks concessions for Indian firms with FDA approval or GMP certification, and proposes using Australian professionals to draft a standard that Indian manufacturers can follow to obtain export permission; it also notes Australia's reversal of its uranium ban and urges conclusion of a Comprehensive Economic Cooperation Agreement to enhance market access and regulatory cooperation. en-us Thu, 17 Nov 2011 18:31:51 +0530 Thu, 17 Nov 2011 18:31:51 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=2427 The statement identifies non tariff barriers to pharmaceutical trade arising from the Therapeutic Goods Administration approval process, which lacks concessions for Indian firms with FDA approval or GMP certification, and proposes using Australian professionals to draft a standard that Indian manufacturers can follow to obtain export permission; it also notes Australia's reversal of its uranium ban and urges conclusion of a Comprehensive Economic Cooperation Agreement to enhance market access and regulatory cooperation. News - Thu, 17 Nov 2011 18:31:51 +0530 https://www.taxtmi.com/news?id=2427